Report: State tobacco prevention funding lacking

May 24, 2012 By MICHAEL FELBERBAUM , AP Tobacco Writer in Health

(AP) -- States have spent only about 3 percent of the billions they've received in tobacco taxes and legal settlements over the last decade to fund tobacco prevention programs, making it harder to reduce the death and disease caused by tobacco use, according to a report released Thursday by the federal Centers for Disease Control and Prevention.

Between 1998 and 2010, have collected nearly $244 billion in cigarette taxes and settlement money, compared with only $8.1 billion earmarked for state efforts. The numbers are far less than the minimum of $29.2 billion the CDC said should have been spent over that same period.

While states on average have never spent as much the CDC would like, the total has declined dramatically in recent years as states grapple with that have forced layoffs, furloughs and cuts for basic services. Many also have raised in order to increase revenue and supplement funds provided by the tobacco industry.

About 46 million Americans smoke, while more than 3 percent of American adults use smokeless tobacco, according to the CDC. And tobacco-related diseases are responsible for about 443,000 deaths a year in the U.S. If states were to use a greater portion of the tax and settlement money for tobacco control and prevention programs, they could achieve larger, more rapid reductions in tobacco use and health-care costs, as well as lower tobacco-related death and disease, the report said.

"We understand that there are severe and that they have difficult choices to make," CDC Director Dr. Thomas Frieden said in a telephone interview with The Associated Press. "Not investing in tobacco control is not only penny wise and pound foolish, but it's also costing lives."

According to the report, states that have spent larger amounts on tobacco control programs have seen fall about twice as much as in the U.S. overall. Smoking prevalence also has declined faster as anti-tobacco spending increased in states like Arizona, California, Massachusetts, Minnesota, Maine, New York, Oregon and Washington, the report said. However, other factors like smoking bans also could have contributed to those reductions.

Frieden said that while states are lacking in prevention funding, tobacco companies continue to spend billions on marketing. The industry spent $10.5 billion to market their products in 2008, the most recent year tracked by the Federal Trade Commission. In that same year, state anti-tobacco funding was about $779 million, according to the report.

"The tobacco companies are out there doing everything they can do, and they have gobs of money to do it," said Stanton Glantz, a tobacco researcher who directs the Center for Tobacco Control Research and Education at the University of California, San Francisco.

"You don't need to meet them dollar for dollar, you just need to be out there with enough to counter them. ... It's easier to sell the truth than a lie."

In addition to raising tobacco taxes from an average of 39 cents per pack in 1998 to $1.44 per pack in 2010, states continue to receive millions of dollars every year from the in the form of a long-standing legal settlement.

Tobacco companies agreed in 1998 to settle lawsuits several states brought over smoking-related by paying them about $206 billion over more than two decades, but the settlement did not require the money be used for anti-tobacco and stop smoking programs. States first received full payments under the settlement in 1999. The largest U.S. tobacco company, Altria Group Inc. - based in Richmond, Va., and maker of Skoal smokeless tobacco and top-selling Marlboro cigarettes - pays a majority of that.

"Today, there's more tobacco-generated revenue available to the states, as well as the federal government, than ever before to fund proven efforts that can prevent underage tobacco use," said Altria spokesman Ken Garcia. "Obviously there's a large spend opportunity to put toward these programs that will help further reduce underage use and promote cessation."

More information: Report: http://www.cdc.gov/mmwr/

©2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Driving and hands-free talking lead to spike in errors, study shows

Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.

Health created 21 hours ago | popularity not rated yet | comments 0

About one in four uninsured could be excluded from ACA

(HealthDay)—More than one in four of those eligible for new premium assistance tax credits under the Affordable Care Act (ACA) do not have a checking account and will not be able to receive premiums from ...

Health created 23 hours ago | popularity not rated yet | comments 0

Audiologists recommend smart phone apps to monitor noise levels

After studying noise in one French Quarter neighborhood of New Orleans to determine whether or not noise levels exceeded municipal ordinances, Annette Hurley, PhD, Assistant Professor of Audiology at LSU Health Sciences Center ...

Health created May 24, 2013 | popularity not rated yet | comments 0

Young children who miss well-child visits are more likely to be hospitalized

Young children who missed more than half of recommended well-child visits had up to twice the risk of hospitalization compared to children who attended most of their visits, according to a study published today in the American Jo ...

Health created May 24, 2013 | popularity not rated yet | comments 0

Do doctors understand the individualisation of treatments?

The individualisation of drug treatments to support patients to self-manage their conditions is a concept that sits at the heart of policy, but a recent study in BMJ Open shows that there is no concrete defini ...

Health created May 24, 2013 | popularity 3 / 5 (1) | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.